Last reviewed · How we verify

NCT03143842

Investigating Accelerated Learning in Tinnitus Participants Implanted With Vagus Nerve Stimulation

Withdrawn NA Last updated 28 January 2022
What this trial tests

NA trial testing Vagus Nerve Stimulation in VNS Implanted Tinnitus Patients. Withdrawn.

Timeline
27 April 2017
Primary endpoint
22 April 2020
25 January 2022

Quick facts

Lead sponsorThe University of Texas at Dallas
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Start date27 April 2017
Primary completion22 April 2020
Estimated completion25 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas at Dallas

Who can join

Adults 18 to 70, any sex, with VNS Implanted Tinnitus Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether it is possible to accelerate learning and improve memory performance in VNS implanted tinnitus participants by pairing VNS with a verbal paired-associate learning task.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vagus Nerve Stimulation

Trials testing the same drug.

Other The University of Texas at Dallas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03143842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing